Evidence map›Paper›PMID 25950690›Full record

Trial reportMedicine2015

Positron Emission Tomography With 18F-Fluorodeoxyglucose in Patients With Sickle Cell Acute Chest Syndrome.

Nicolas de Prost, Myriam Sasanelli, Jean-François Deux, Anoosha Habibi, Keyvan Razazi, Frédéric Galactéros, Michel Meignan, Bernard Maître, Christian Brun-Buisson, Emmanuel Itti and 1 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Nicolas de ProstFrom the Assistance Publique-Hôpitaux de Paris (NP, KR, CB-B, AMD), Hôpitaux Universitaires Henri Mondor, DHU A-TVB, Service de Réanimation Médicale; UPEC-Université Paris-Est Créteil Val de Marne (NP, KR, CB-B, AMD), Faculté de Médecine de Créteil, CARMAS Research Group; UPEC-Université Paris-Est Créteil Val de Marne (MS, J-FD, AH, FG, MM, BM, EI), Faculté de Médecine de Créteil; Assistance Publique-Hôpitaux de Paris (MS, MM, EI), Hôpitaux Universitaires Henri Mondor, Service de Médecine Nucléaire; Assistance Publique-Hôpitaux de Paris (J-FD), Hôpitaux Universitaires Henri Mondor, Service de Radiologie; Assistance Publique-Hôpitaux de Paris (AH, FG), Hôpitaux Universitaires Henri Mondor, Unité des Maladies Génétiques du Globule Rouge - Service de Médecine Interne; and Assistance Publique-Hôpitaux de Paris (BM), Hôpitaux Universitaires Henri Mondor Antenne de Pneumologie, Service de Réanimation Médicale, Créteil, France.
Myriam Sasanelli
Jean-François Deux
Anoosha Habibi
Keyvan Razazi
Frédéric Galactéros
Michel Meignan
Bernard Maître
Christian Brun-Buisson
Emmanuel Itti
Armand Mekontso Dessap
Fondation pour la Recherche Médicale · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The acute chest syndrome (ACS) is the main cause of mortality among adult patients with sickle cell disease (SCD). Its pathophysiology is still unclear. Using positron emission tomography (PET) with F-fluorodeoxyglucose [18F-fluorodeoxyglucose (F-FDG)], we explored the relationship between regional lung density and lung metabolism, as a reflection of lung neutrophilic infiltration during ACS.Patients were prospectively enrolled in a single-center study. Dual modality chest PET/computed tomography (CT) scans were performed, with F-FDG emission scans for quantification of regional F-FDG uptake and CT scans with radiocontrast agent to check for pulmonary artery thrombosis. Regional lung F-FDG uptake was quantified in ACS patients and in SCD patients without ACS (SCD non-ACS controls). Maximal (SUVmax) and mean (SUVmean) standardized uptake values were computed.Seventeen patients with ACS (mean age 28.3 ± 6.4 years) were included. None died nor required invasive mechanical ventilation. The main lung opacity on CT scans was lower lobe consolidation. Lungs of patients with ACS exhibited higher SUVmax than those of SCD non-ACS controls (2.5 [2.1-2.9] vs 0.8 [0.6-1.0]; P < 0.0001). Regional SUVmax and SUVmean was higher in lower than in upper lobes of ACS patients (P < 0.001) with a significant correlation between lung density and SUVmax (R = 0.78). SUVmean was higher in upper lobes of ACS patients than in lungs of SCD non-ACS controls (P < 0.001). Patients with SUVmax >2.5 had longer intensive care unit (ICU) stay than others (7 [6-11] vs 4 [3-6] days; P = 0.016).Lungs of patients with ACS exhibited higher F-FDG uptake than SCD non-ACS controls. Lung apices had normal aeration and lower F-FDG uptake than lung bases, but higher F-FDG uptake than lungs of SCD non-ACS controls. Patients with higher lung F-FDG uptake had longer ICU stay than others.

Indexed as

Fluorodeoxyglucose F18Positron-Emission TomographyRadiopharmaceuticalsAcute Chest SyndromeAdultFemaleHumansMaleMiddle AgedNeutrophil InfiltrationProspective StudiesTomography, X-Ray ComputedFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID25950690
PMCPMC4602525
OpenAlexW585437525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.